Table III.
Association between Lewis y and TGF-β1 expression and pathological features.
| Lewis y antigen | TGF-β1 | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| Features | n | Positive cases (n) | Rate (%) | P-value | Positive cases (n) | Rate (%) | P-value |
| Pathological type | |||||||
| Mucous | 30 | 26 | 86.67 | P>0.05 | 25 | 83.33 | P>0.05 |
| Serous | 30 | 27 | 90.00 | 22 | 73.33 | ||
| FIGO stage | |||||||
| I–II | 39 | 33 | 84.62 | P>0.05 | 29 | 74.36 | P>0.05 |
| III–IV | 21 | 20 | 95.24 | 18 | 85.71 | ||
| Differentiation level | |||||||
| High | 21 | 17 | 80.95 | P>0.05 | 17 | 80.95 | P>0.05 |
| Middle | 21 | 18 | 85.71 | 16 | 76.19 | ||
| Low | 18 | 18 | 100.00 | 14 | 77.78 | ||
| Lymphatic metastasis | |||||||
| No | 48 | 41 | 85.42 | P>0.05 | 36 | 75.00 | P>0.05 |
| Yes | 12 | 12 | 100.00 | 11 | 91.67 | ||